FDA Launches PreCheck Program to Boost US Drug Manufacturing
The US Food and Drug Administration (USFDA) has unveiled a new program aimed at strengthening the domestic pharmaceutical supply chain by increasing regulatory predictability and facilitating the construction of manufacturing sites in the United States.
US Drug Manufacturing | 11/08/2025 | By Dineshwori
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy